Home > Products > Antibodies > Biosimilars

Research Grade Odesivimab (VK623026)

Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview
  • Images
  • References
  • Datasheet
Overview
Catalog No.VK623026
Species reactivityZaireebolavirus(ZEBOV)
ApplicationsResearch Grade Biosimilar
Host speciesHuman
IsotypeIgG1, kappa
Expression systemMammalian Cells
ClonalityMonoclonal
TargetEnvelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP
Concentration2.53mg/ml
Endotoxin levelPlease contact the lab for this information.
Purity>95% purity as determined by SDS-PAGE.
PurificationProtein A/G, purified from cell culture supernatant.
AccessionQ05320
FormLiquid
Storage buffer0.01M PBS,pH7.4.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -633°C.
Alternate NamesREGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,REGN-EB3,REGNEB3,Inmazeb(atoltivimab,maftivimab,odesivimab-ebgn),CAS:2135632-30-1
BackgroundOdesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection.
NoteFor research use only. Not for use in clinical or therapeutic applications.
Images
  • Bioactivity

    SEC-HPLC detection for Research Grade Odesivimab.

References

Recommendation